[Federal Register Volume 63, Number 230 (Tuesday, December 1, 1998)]
[Notices]
[Page 66191]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-31921]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.

    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel. A contract proposal concerning the use of 2-deoxyglucose as 
an anti-aging agent.
    Date: December 11, 1998.
    Time: 1:00 PM to 3:00 PM.
    Agenda: To review and evaluate contract proposals.
    Place: 7201 Wisconsin, Suite 502C, Bethesda, MD 20892, 
(Telephone Conference Call).
    Contact Person: Arthur D. Schaerdel, DVM, Scientific Review 
Administrator, The Bethesda Gateway Building, 7201 Wisconsin Avenue/
Suite 2C212, Bethesda, MD 20892, (301) 496-9666.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: November 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-31921 Filed 11-30-98; 8:45 am]
BILLING CODE 4140-01-M